🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

APOL1 Genetic Testing at No Cost to Patients! Are you incorporating APOL1 genetic testing into your workflow? Discover No-Cost APOL1 Genotyping Program for eligible patients sponsored by Vertex Pharmaceuticals. Learn more today! #KidneyHealth #GeneticTesting

This may be the most disturbing thing yet I’ve heard out of HHS. Likely AI generated fake references using real author’s names. If the studies don’t exist, how can the science be sound? Is AI destined to be backed by false claims as it creates more and more references on its own?

Core Curriculum by J Pedro Teixeira (a.k.a. Jwow), Swapnil Hiremath @hswapnil.medsky.social, Abdulghani Kabli, Oleksa Rewa, and Edward (Ted) Clark MD MSc: Continuous Kidney Replacement Therapies bit.ly/TeixeiraCC25 (FREE)

2025 June ASN Publications ASN Kidney News Nephrocentric Greek Tragedies - Artwork by Brian Rifkin, MD kidneynews.org/view/journals/…

On Tuesday 6/10/25 at 9pm only on #Bluesky we are discussing Tacrolimus vs MMF in pediatric nephrotic syndrome 👶, the STAMP 🦶 trial. School might be out for summer ⛱️🌞, but we're still holding class #NephTwitter !! 📚 nephjc.com/news/stamp

Sometimes we are just overflowing with creativity at #NephJC, check out our twin👶👶 VAs for MMF vs TAc in pediatric nephrotic syndrome nephjc.com/news/2025/6/8/… nephjc.com/news/2025/6/ta…

Our editorial with Dr Priti MD,FASN🇮🇳 (प्रिति) in AJKD Why are women still left behind in kidney transplantation? Excellent study by JessicaHarding Rachel Patzer Ana Rossi, MD MPH | FASN | FAST et al Despite being more likely to donate ❤️‍🩹, women remain less likely to receive a kidney transplant 🧬.

🚨#SGLT2 inhibitors in cirrhosis? Where #Nephrology meets #Hepatology 🧪11/11:↓ ascites (💧less taps) 📉7/9: slowed progression (fewer decompensations) ⚠️AKI/hypotension in refractory cases—balance matters! Dual win:Natriuresis + anti-inflammatory 🔗 doi.org/10.3390/ijms26…

A completely AI 🤖 generated podcast based upon source material (blog and paper) for tomite’s #NephJC discussion podcasts.apple.com/us/podcast/fre…

Discover how Rapamycin impacts Kir4.1/Kir5.1, NCC, and renal K+ excretion. Uncover the connection between mTORc1 inhibition in the DCT and these processes. Learn more at: bit.ly/JASN0727 #ASNJASN #BasicResearch

📣 Calling medical and graduate students, residents, and fellows: Only one week left to apply for travel support to attend ASN #KidneyWk 2025 in Houston, TX. Explore all programs and apply now: asn.kdny.info/blhT50W7RM5 🗓️ Deadline: Wednesday, June 18, 2 p.m. EDT

Understanding how diabetes affects the kidneys and exploring new treatment options is of critical importance. We present a special collection of articles on Diabetes and Kidney Disease: bit.ly/3wpQ6vg (FREE until July 1, 2025)

Many kidney patients on the transplant waitlist are unaware when their transplant team has declined a particular organ on their behalf. We want to change that. kidney.quorum.us/campaign/10282…

RFK Jr. went on national TV and spouted egregious, dangerous falsehoods about vaccines. As a parent and infectious diseases doctor, I couldn't stay silent. Fox News might not fact-check him, but I will. I've reviewed the trials. I've catalogued them. I have receipts. 🧵

Acute Kidney Injury Induced by Immune Checkpoint Inhibitors

"Clinical Nephrology Insights" Review in #ASNJASN discusses the progress in discovering autoantigens in membranous nephropathy, highlighting the importance of considering the varying strength of association between certain antigens and underlying conditions.

1/📢Hey #NephTwitter #MedTwitter! Welcome to a 🆕 #tweetorial #xtorial brought to you by KIReports Int Society of Nephrology ISN Education. Our author is Kajaree Giri nephrologist at Indus Hospitals, Indus Hospitals(Ind) India Please also check out #KIReportsCommunity educational #blogposts

Fellow Michael Strader reflects on the limitations of functional biomarkers for AKI, and how novel biomarkers could make the clinical characterization of AKI more precise. kidney.pub/KN1706-06 #ASNKidneyNews

1/  🚨📢 Tweetorial alert! We know that cisplatin is a usual suspect for AKI in an onconephrology setting, but when it causes kidney damage, it can be unpredictable. That’s where this recent urinary biomarker study in KIReports paper comes into play. Let’s start with a quiz! 📝

NEW on the #AJKDBlog: Timothy Yau interviews Roger Rodby and Bill Whittier about all things RTA! Renal Tubular Acidosis: An Interview bit.ly/Rodby25 (FREE)